DE3572807D1 - A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use - Google Patents

A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use

Info

Publication number
DE3572807D1
DE3572807D1 DE8585300793T DE3572807T DE3572807D1 DE 3572807 D1 DE3572807 D1 DE 3572807D1 DE 8585300793 T DE8585300793 T DE 8585300793T DE 3572807 T DE3572807 T DE 3572807T DE 3572807 D1 DE3572807 D1 DE 3572807D1
Authority
DE
Germany
Prior art keywords
salts
preparation
compositions containing
therapeutic use
phenylpiperidine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585300793T
Other languages
English (en)
Inventor
Jorgen Buus Lassen
Jorgen Anders Christensen
Erling Niels Petersen
John Bondo Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Application granted granted Critical
Publication of DE3572807D1 publication Critical patent/DE3572807D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8585300793T 1984-02-07 1985-02-06 A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use Expired DE3572807D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/577,844 US4585777A (en) 1984-02-07 1984-02-07 (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Publications (1)

Publication Number Publication Date
DE3572807D1 true DE3572807D1 (en) 1989-10-12

Family

ID=24310381

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585300793T Expired DE3572807D1 (en) 1984-02-07 1985-02-06 A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use

Country Status (12)

Country Link
US (1) US4585777A (de)
EP (1) EP0152273B1 (de)
JP (1) JPS60181071A (de)
AT (1) ATE46146T1 (de)
CA (1) CA1246082A (de)
DE (1) DE3572807D1 (de)
DK (1) DK53285A (de)
ES (1) ES8601131A1 (de)
FI (1) FI850449L (de)
GR (1) GR850309B (de)
IE (1) IE850286L (de)
NO (1) NO850444L (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223334B1 (de) * 1985-08-10 1991-07-10 Beecham Group Plc Verfahren zur Herstellung von Arylpiperidincarbinol
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
AU7708998A (en) 1997-05-29 1998-12-30 Smithkline Beecham Corporation Novel process
PT994872E (pt) 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
AU2002301956B2 (en) * 1997-06-10 2006-02-09 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
AU2000246280A1 (en) 2000-05-12 2001-11-20 Synthon B.V. Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols
AU2001270858A1 (en) * 2000-07-17 2002-01-30 Smithkline Beecham Plc Novel processes for the preparation of 4-phenylpiperidine derivatives
WO2002028834A1 (en) * 2000-10-06 2002-04-11 Smithkline Beecham P.L.C. Process for the preparation of aryl-piperidine carbinols and intermediates thereof
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
US6930186B2 (en) 2001-06-13 2005-08-16 Teva Pharmacetical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
EP2727915B1 (de) * 2007-09-13 2016-04-13 Concert Pharmaceuticals Inc. Synthese von deuterierten Catecholen und Benzo[D][1,3]dioxolen und Derivate davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Also Published As

Publication number Publication date
DK53285D0 (da) 1985-02-06
IE850286L (en) 1985-08-07
EP0152273A3 (en) 1986-12-30
ES540172A0 (es) 1985-11-16
US4585777A (en) 1986-04-29
EP0152273A2 (de) 1985-08-21
ATE46146T1 (de) 1989-09-15
JPS60181071A (ja) 1985-09-14
NO850444L (no) 1985-08-08
JPS6135176B2 (de) 1986-08-12
ES8601131A1 (es) 1985-11-16
CA1246082A (en) 1988-12-06
DK53285A (da) 1985-08-08
FI850449L (fi) 1985-08-08
FI850449A0 (fi) 1985-02-04
EP0152273B1 (de) 1989-09-06
GR850309B (de) 1985-06-05

Similar Documents

Publication Publication Date Title
DE3572807D1 (en) A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
HK125993A (en) Piperidine derivative,its preparation,and its use as medicament
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
HUT49601A (en) Process for producing piperazine derivatives and salts thereof, as well as pharmaceutical compositions comprising such piperazine deriatives and salts thereof
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
DE3170245D1 (en) Indane derivatives, methods of their preparation and compositions containing them
AU2091588A (en) New imidazolidines substituted by a hydroxymethyl radical and a substituted phenyl radical, the process for their preparation, their use as medicaments, the pharmaceutical compositions containing them and an intermediate for their preparation
AU1331588A (en) Method for treatment of alcohol abuse
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
ES8800679A1 (es) Un procedimiento para preparar derivados de piperiliden-dihidrodibenzo-(a,d)-cicloheptenos y derivados aza
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AU6697786A (en) New derivatives of 1-sulphonyl 2-oxo-5-alkoxy pyrrolidine, their preparation process, their use as medicaments and the compositions containing them
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
IL87016A (en) Phenylpiperidine derivatives, their preparation and pharmaceutical compositions containing them
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
JPS5728031A (en) Ethylenediamine derivative and medicinal composition as effective component thereof
EP0329563A3 (en) Benzocyclohexane and benzocycloheptane derivatives and their salts, process and intermediates for their preparation, their use as medicines and compositions containing them
AU5649286A (en) New derivatives of 4-phenylpropyl indole and their salts, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
DE2966234D1 (en) Isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same
ZA894098B (en) Alpha-adrenergic receptor antagonists
JPS6438073A (en) Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee